A revolutionary tech has the potential to eradicate womb cancer screening in the UK, a significant blow to patient lives. Several NHS hospitals have been preparing to use an AI-powered blood test to assess women referred for possible womb cancer before invasive checks are carried out. According to The Guardian, around 90,000 postmenopausal women in England are referred by GPs each year for these tests after experiencing heavy bleeding.
The blood test is designed to detect biomarkers that may indicate the presence of womb cancer, allowing doctors to rule out the condition without resorting to invasive tests like ultrasounds or biopsies. The AI-powered technology is expected to significantly reduce the number of unnecessary checks and treatments, which can be traumatic for patients who are already suffering from this debilitating disease.
The use of AI in healthcare has been gaining momentum in recent years, with numerous studies showing its potential to improve diagnosis accuracy and patient outcomes. With this new test, NHS hospitals hope to streamline the screening process, allowing doctors to focus on more pressing issues while also providing better care for their patients.